Ionis to host 2024 virtual Annual Meeting of Stockholders

Core Insights - Ionis Pharmaceuticals will hold its 2024 virtual Annual Meeting of Stockholders on June 6, 2024, followed by a corporate update [1] - The company has a strong pipeline in neurology, cardiology, and other high-need areas, with five marketed medicines [1] Company Overview - Ionis Pharmaceuticals has been innovating medicines for serious diseases for three decades [1] - The company is a pioneer in RNA-targeted medicines and is advancing new approaches in gene editing [1] - Ionis emphasizes a deep understanding of disease biology and industry-leading technology to drive innovation [1] Meeting Details - The virtual Annual Meeting will take place from 5:00 p.m. to 5:15 p.m. ET, with a corporate update at 5:30 p.m. ET [3] - Stockholders of record as of April 8, 2024, are invited to participate and will receive a proxy card for access [3] - A help line will be available for technical assistance during the live event, which will not have a replay [3]